mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal
Gestational Diabetes Mellitus (GDM), Pregnancy Induced Hypertension (PIH), Anemia
About this trial
This is an interventional health services research trial for Gestational Diabetes Mellitus (GDM) focused on measuring Antenatal care, Pregnancy care, Pregnancy complications, Pregnancy Induced Hypertension, Gestational Diabetes Mellitus, Anemia
Eligibility Criteria
Inclusion Criteria:
- Pregnant women visiting a trial facility up to the end of the 28th week of gestation
- Women who are planning to remain within the five study districts until at least one-month post-partum OR women whose mothers reside in the selected districts
Exclusion Criteria:
• Women coming to the trial facility for a non-routine ANC visit (for example, to get a laboratory investigation, to collect a report or her medicine)
Sites / Locations
- Primary Health Centres (PHCs)
- Primary Health Centres (PHCs)
- Primary Health Centres
- Primary Health Centres (PHCs)
- Primary Health Centres (PHCs)
- Health posts
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
mHealth integrated model of hypertension, diabetes, anemia, and antenatal care
Routine antenatal care
The mIRA trial intervention will consist of an electronic decision support system (EDSS), provided to healthcare providers at primary-level facilities in India and Nepal to deliver enhanced ANC with improved detection and management of pregnancy-induced hypertension (PIH), gestational diabetes mellitus (GDM) and anemia.
In the control clusters, pregnant women will receive the existing standard of care (usual care) from Frontline Health Workers (FHWs). Evidence-based guidelines in the form of posters/pamphlets on current national and state guidelines on screening and management of pregnancy-induced hypertension (PIH), gestational diabetes mellitus (GDM), anemia, and routine ANC procedures will be provided to all the control health facilities.